Muhammad Absar, Nawaf Alanazi, Abdulaziz Siyal, et al. CLINICAL VALIDATION OF ANKRD36 MUTATIONS AS A NOVEL BIOMARKER FOR MONITORING EARLY PROGRESSION AND TIMELY CLINICAL INTERVENTIONS IN BLAST CRISIS CML. J Popl Ther Clin Pharmacol. 2022;29(02):311-320. doi:10.53555/jptcp.v29i02.4161